一种网络毒理学方法来破译乳腺癌发病过程中类诱导的分子失调
Wen Zhang1, Rui Xiang2, Wang Gu2
1Department of Endocrinology and Metabolism, The Traditional Chinese Medicine Hospital of Luzhou City, Luzhou, Sichuan, China.
Discover oncology
|June 13, 2025
概括
素是常见的防腐剂,通过破坏激素和向ESR1和ESR2等关键分子,可能会增加乳腺癌的风险. 这项研究揭示了它们与乳腺癌免疫抑制的潜在联系.
科学领域:
- 环境毒理学环境毒理学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 烯是广泛使用的防腐剂,具有抗微生物特性,可在化品,药品和食品中找到.
- 它们是可以生物累积的环境污染物,与内分泌干扰和乳腺癌等疾病有关.
- 准确的分子机制,帕拉有助于乳腺癌的形成并未完全理解.
研究的目的:
- 阐明了帕拉本诱导的乳腺癌发病的基础分子机制.
- 通过网络毒理学和分子对接,识别乳腺癌中对的关键分子标.
主要方法:
- 从PubChem获得了对的结构,并使用ProTox和ADMETlab进行了毒理学分析.
- 使用STITCH和SwissTargetPrediction预测了对蛋白相互作用.
- 从GeneCards,OMIM和TTD中策划了与乳腺癌相关的目标,随后进行了网络构建,途径分析 (GO,KEGG) 和分子对接.
主要成果:
- 总共确定了13个帕拉本行动目标和与乳腺癌相关的目标之间的交叉目标.
- 网络分析强调ESR1,ESR2,SERPINE1和CA2作为中心蛋白质.
- 确定了三个核心标 (ESR1,ESR2,SERPINE1),它们显示出强烈的与帕拉本结合以及与乳腺癌中免疫细胞透的相关性.
结论:
- 烯具有雌激素活性,通过向ESR1,ESR2和SERPINE1.1,可以促进乳腺癌的发展.
- 这些相互作用可能调节涉及全身免疫抑制或乳腺癌炎症反应受损的途径.
- 这些发现凸显了对对在乳腺癌病因和进展中的作用进行进一步调查的必要性.
相关概念视频
Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


